글로벌 국소 각질 용해제 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

국소 각질 용해제 시장 분석

국소 각질 용해제는 건선 증상을 관리하는 데 사용됩니다. 살리실산 및 콜타르와 같은 각질 용해제는 건선 플라크의 특징인 두껍고 비늘 같은 패치를 부드럽게 하고 제거하는 데 사용됩니다. 이러한 약물은 죽은 피부 세포를 제거하고 다른 국소 치료제의 침투를 용이하게 하여 건선과 관련된 비듬, 가려움증 및 염증을 줄이는 데 도움이 됩니다. 국소 각질 용해제 시장은 건선 관리에 대한 효과적인 솔루션에 대한 수요를 충족시켜 환자에게 불편함과 상태의 눈에 띄는 증상으로부터 완화를 제공하는 동시에 피부 건강을 개선합니다.

국소 각질 용해제 시장 규모

글로벌 국소 각질 용해제 시장 규모는 2023년에 15억 달러로 평가되었으며, 2031년까지 23억 1천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 5.56%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

Topical Keratolytics Market Definition

Topical keratolytics are medications or treatments applied directly to the skin to help remove dead or thickened skin cells. They work by breaking down the keratin protein that makes up the outer layer of the skin, promoting exfoliation and revealing smoother, healthier skin underneath. Common ingredients in topical keratolytics include salicylic acid, urea, lactic acid, and coal tar. These agents are used to treat various skin conditions such as acne, psoriasis, calluses, and warts, by softening rough patches, reducing inflammation, and improving the overall appearance and texture of the skin.

Topical Keratolytics Market Dynamics

Drivers

• Increasing Prevalence of Various Skin Conditions Leads to the Rising Demand for Topical Keratolytics

Skin conditions such as acne, psoriasis, keratosis pilaris, and hyperkeratosis directly drives the demand for topical keratolytics. As these conditions affect millions of individuals worldwide, there is a substantial and growing market for products that address their symptoms and improve skin health. With skin issues being common across age groups and demographics, the demand for effective topical treatments remains consistently high. Consequently, pharmaceutical companies and skincare manufacturers invest in research and development to innovate new formulations and improve existing treatments, catering to the needs of this expansive market segment. As awareness about skincare increases and more individuals seek treatment for their skin concerns, the demand for topical keratolytics is expected to continue its upward trajectory.

• Growing Prevalence of Age-Related Skin Promotes the Adoption of Topical Keratolytics

As individuals age, they experience changes in skin texture, including dryness, roughness, and increased keratinization. Topical keratolytics are in high demand among the elderly population to address these issues by promoting exfoliation, softening rough patches, and improving overall skin health and appearance. With a growing aging demographic globally, the demand for topical keratolytics as part of skincare regimens is expected to continue to rise, driving market growth and presenting opportunities for manufacturers to develop specialized products catering to this demographic's unique needs.

Opportunities

• Growing Technological Advancements Provides Effective Skincare Solutions

Innovations in delivery systems, such as microencapsulation and nanotechnology, enhance the penetration of active ingredients, leading to improved efficacy and patient compliance. Formulation advancements also enable the development of combination therapies, allowing for synergistic effects and targeted treatment of multiple skin conditions simultaneously. Moreover, novel formulations address specific patient needs, such as sensitive skin or acne-prone skin, expanding the market reach and catering to diverse consumer preferences. These advancements foster product differentiation, competitive advantage, and market growth within the topical keratolytics segment, driving innovation and meeting evolving consumer demands for effective and convenient skincare solutions.

• Increasing Disposable Income among Consumers allows Consumers to Explore a Wider Range of Skincare Options

With higher disposable income levels, individuals are more willing to invest in skincare products to address concerns related to skin health and appearance. This trend enables consumers to afford premium and specialized topical keratolytics formulations, leading to an expansion in the market for both therapeutic and cosmetic purposes. Manufacturers can capitalize on this opportunity by developing innovative products with enhanced efficacy and cosmetic appeal, targeting affluent consumer segments. Moreover, the availability of discretionary income allows consumers to explore a wider range of skincare options, driving demand for premium and niche topical keratolytics products, thereby fostering market growth and innovation.

Restraints/Challenges

• Side Effects and Skin Sensitivity Concerns among the Consumers

While these treatments are effective for many, adverse reactions such as irritation, redness, and burning sensations can deter patients from continued use. Skin sensitivity varies widely among individuals, making it challenging to develop universally well-tolerated formulations. Concerns about potential side effects may discourage both patients and healthcare providers from prescribing or recommending topical keratolytics, leading to reduced market uptake and impacting revenue potential for manufacturers.

• Growing Regulatory Hurdles leads to the Increasing Costs for Manufacturers

Stricter regulations surrounding product testing, safety assessments, and approval processes lengthen the time and resources required to bring new products to market. Compliance with evolving regulatory standards necessitates extensive documentation and quality control measures, further adding to manufacturing expenses. These escalating costs are often passed on to consumers, resulting in higher prices for topical keratolytic products. Consequently, this barrier may inhibit market entry for smaller manufacturers and limit innovation, ultimately constraining market growth and accessibility for patients seeking effective dermatological treatments.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Topical Keratolytics Market Scope

The market is segmented on the basis of indication, dosage form, agents, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Indication

• Psoriasis
• Dry Skin
• Acne Vulgaris
• Warts
• Dandruff
• Others

Dosage Form

• Shampoo
• Gel
• Solution
• Face Wash
• Lotion
• Creams
• Others

Agents

• Urea
• Salicylic Acid
• Lactic Acid
• Alpha Hydroxy Acids
• Propylene Glycol
• Others

End-Users

• Hospitals
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

Topical Keratolytics Market Regional Analysis

The market is analysed and market size information is provided by country, indication, dosage form, agents, end-users and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America dominates the market, primarily attributed to its advanced research and development facilities, substantial healthcare spending, proficient workforce, and the presence of major product manufacturers.

Europe follows as the second-largest market, driven by a rising incidence of skin-related ailments. The region's healthcare infrastructure and growing awareness about skincare contribute to the significant demand for topical keratolytics, positioning Europe as a key market player in the industry.

아시아 태평양 지역은 앞으로 몇 년 동안 시장이 성장할 것으로 예상되는데, 이는 주로 여러 요인 때문입니다. 이 지역에서는 스킨케어 및 미용 제품을 홍보하는 캠페인이 급증하면서 이러한 치료에 사용되는 국소 각질 용해제에 대한 수요가 증가했습니다. 또한 이 지역에서는 제네릭 의약품에 대한 선호도가 높아지고 있어 시장 확장에 기여하고 있습니다. 이러한 요인의 조합으로 인해 아시아 태평양 지역은 국소 각질 용해제 시장의 최전선에 서서 가까운 미래에 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

국소 각질 용해제 시장 점유율

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 임상 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 프로그램 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• 브리스톨-마이어스 스퀴브 회사(미국)
• Galderma Laboratories, LP(스위스)
• 타로제약산업(이스라엘)
• Par Pharmaceutical, Inc. (미국)
• Avita Medical, Inc. (미국)
• BIOFRONTERA AG(독일)
• 스키톤(미국)
• 루메니스 비 유한회사(이스라엘)
• 알마 레이저(이스라엘)
• 사이노슈어 주식회사(미국)

국소 각질 용해제 시장의 최신 동향

• 2023년 10월, FDA는 클린다마이신 인산염, 아다팔렌, 과산화벤조일을 함유한 국소 젤인 Cabtreo에 대한 승인을 12세 이상 환자의 여드름을 치료하는 데 승인했습니다. 클린다마이신 인산염은 여드름을 유발하는 박테리아를 감소시키는 항생제이고, 아다팔렌은 모공 막힘을 제거하고 염증을 줄이는 레티노이드이며, 과산화벤조일은 박테리아를 죽이고 과도한 피지 생성을 줄이는 작용을 합니다. 이 조합은 여드름 치료에 대한 포괄적인 접근 방식을 제공하며, 여드름의 발병에 기여하는 여러 요인을 타겟팅하고 효과적인 피부 관리 솔루션을 찾는 환자에게 유망한 옵션을 제공합니다.

SKU-60304